CEFOTAXIME
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | CEFOTAXIME |
| DrugBank ID | DB00493 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 53 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| arthropathy | TxGNN Knowledge Graph | L5 |
| urinary tract infection (disease) | TxGNN Knowledge Graph | L5 |
| sinusitis | TxGNN Knowledge Graph | L5 |
| actinomycosis | TxGNN Knowledge Graph | L5 |
| spotted fever | TxGNN Knowledge Graph | L5 |
| relapsing fever | TxGNN Knowledge Graph | L5 |
| conjunctivitis | TxGNN Knowledge Graph | L5 |
| gonococcal epididymo-orchitis | TxGNN Knowledge Graph | L5 |
| rocky mountain spotted fever | TxGNN Knowledge Graph | L5 |
| cat-scratch disease | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11